Intelligence · Patents
Patents expiring in 2038
Annual patent cliff calendar for 2038 — US pharmaceutical patents by expiration date.
- Patents
- 1,509
Quick answer
1,509 indexed pharmaceutical patents have expiration dates in 2038. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9962385
Methods and compositions for treating abnormal cell growth
granted -
US 9962377
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted -
US 9962448
Compounds and methods for targeted immune system delivery
granted -
US 9963478
Mannose derivatives for treating bacterial infections
granted -
US 9963700
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
WO 2018083171
COMPOSÉS SPIRO EN TANT QUE MODULATEURS DE S1P
granted -
US 9968674
Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody
granted -
US 9969705
Fused heterocyclic compound
granted -
US 9970037
Methods and materials for making simvastatin and related compounds
granted -
US 9968641
Method to suppress the systemic toxicity of chemotherapeutic drugs
granted -
US 9968642
Compositions and methods for treatment of pain
granted -
US 9968613
Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
granted -
US 9968644
Traditional chinese medicine composition for sober-up and hepatic protection and a process for preparing the same
granted -
US 9968586
Mast cell stabilizers treatment for systemic disorders
granted -
US 9968598
Process of making stable abuse-deterrent oral formulations
granted -
US 9968595
Pharmaceutical compositions of therapeutically active compounds
granted -
US 9968587
Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio
granted -
US 9968612
Method of synthesizing thyroid hormone analogs and polymorphs thereof
granted -
US 9968693
Small molecule imaging of fungi by positron emission tomography scanning
granted -
US 9968664
Fusion molecule based on novel TAA variant
granted -
US 9970006
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
granted -
US 9970059
Survival predictor for diffuse large B cell lymphoma
granted -
US 9969804
Methods and compositions for treating and preventing disease associated with alpha-V beta-8 integrin
granted -
US 9969970
DNA-cell conjugates
granted -
US 9969790
Compositions and methods for immunomodulation in an organism
granted -
US 9969998
Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
granted -
US 9969975
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9969754
Compounds for treating spinal muscular atrophy
granted -
US 9968669
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
granted -
US 9969742
Imidazotriazinone compounds
granted -
US 9969709
Guanidinobenzoic acid ester compound
granted -
US 9969719
Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
granted -
US 9968631
Method for treatment of pulmonary fibrosis
granted -
US 9968638
Compositions and methods for transplantation of colon microbiota
granted -
US 9968653
Angiopoietin-based interventions for treating cerebral malaria
granted -
US 9969803
Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof
granted -
US 9969777
Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)
granted -
US 9969695
N-substituted imidazole carboxylic ester chiral compound containing an ether side chain, its preparation and application
granted -
EP 3320902
VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT ISOINDOLINVERBINDUNGEN
granted -
CA 3043000
DERIVES DE PROSTAGLANDINE LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DU GLAUCOME A TENSION NORMALE
granted -
US 9975983
Bio-reducible self-assembled liquid crystalline block copolymer for drug delivery
granted -
US 9975952
Antibody fragments, compositions and uses thereof
granted -
US 9977033
Methods for assessing cancer recurrence
granted -
US 9975959
Administration of kynurenine depleting enzymes for tumor therapy
granted -
US 9976115
Bone marrow adipose portion isolation device and methods
granted -
US 9976141
Compositions and methods for inhibiting gene expression of Hif2alpha
granted -
US 9976138
Methods and compounds useful in conditions related to repeat expansion
granted -
US 9976123
Cellular seeding and co-culture of a three dimensional fibroblast construct
granted
Frequently asked questions
How many pharma patents expire in 2038?
1,509 published patents in our USPTO index have expiration dates falling in calendar year 2038.